Clinical Observations and Mechanistic Insights of Traditional Chinese Medicine in the Management of Diabetic Retinopathy

Overview

Journal Pharm Biol

Specialties Pharmacology
Pharmacy

Date 2024 Jun 26

PMID 38921697

Authors

Jie Chen

Yadong Ni

Wenhui Yao

Xuansheng Ding

Affiliations

Soon will be listed here.

Abstract

Context: Diabetic retinopathy (DR) is one of the leading causes of vision impairment and blindness among diabetic patients globally. Despite advancements in conventional treatments, the quest for more holistic approaches and fewer side effects persists. Traditional Chinese medicine (TCM) has been used for centuries in managing various diseases, including diabetes and its complications.

Objective: This review evaluated the efficacy and underlying mechanisms of TCM in the management of DR, providing information on its potential integration with conventional treatment methods.

Methods: A comprehensive literature review was conducted using PubMed, Web of Science, and the China National Knowledge Infrastructure (CNKI) with the search terms 'traditional Chinese medicine', 'diabetic retinopathy', 'clinical efficacies' and their combinations. Studies published before 2023 without language restriction were included, focusing on clinical trials and observational studies that assessed the effectiveness of TCM in DR treatment.

Results: The review synthesized evidence of empirical traditional Chinese formulas, traditional Chinese patent medicines, and isolated phytochemicals on DR treatment. The key mechanisms identified included the reduction of oxidative stress, inflammation, and neovascularization, as well as the improvement in neurovascular functionality and integrity of the retinal blood barrier.

Conclusions: TCM shows promising potential to manage DR. More large-scale, randomized controlled trials are recommended to validate these findings and facilitate the integration of TCM into mainstream DR treatment protocols.

Citing Articles

Curcumin and Metformin Infinite Coordination Polymer Nanoparticles for Combined Therapy of Diabetic Mice via Intraperitoneal Injections.

Sun S, Hou X, Li K, Huang C, Rong Y, Bi J J Funct Biomater. 2024; 15(12).

PMID: 39728188 PMC: 11677912. DOI: 10.3390/jfb15120388.

References

Wang Y, Sun X, Xie Y, Du A, Chen M, Lai S . Panax notoginseng saponins alleviate diabetic retinopathy by inhibiting retinal inflammation: Association with the NF-κB signaling pathway. J Ethnopharmacol. 2023; 319(Pt 1):117135. DOI: 10.1016/j.jep.2023.117135. View

Mrugacz M, Bryl A, Zorena K . Retinal Vascular Endothelial Cell Dysfunction and Neuroretinal Degeneration in Diabetic Patients. J Clin Med. 2021; 10(3). PMC: 7866162. DOI: 10.3390/jcm10030458. View

Huo J, Duan J, Liu L, Zhang F, Zhu K, Sui J . Evaluation of individualized treatment of nonproliferative diabetic retinopathy: a multicenter, randomized, parallel-controlled study. J Tradit Chin Med. 2022; 42(1):90-95. PMC: 10164625. DOI: 10.19852/j.cnki.jtcm.20210425.002. View

Cai Y, Tu H, Wu C, Liu T, Chen S, Shen L . Therapeutic potential of elema-1,3,7(11),8-tetraen-8,12-lactam from Curcuma wenyujin on diabetic retinopathy via anti-inflammatory and anti-angiogenic pathways. J Ethnopharmacol. 2023; 318(Pt A):116843. DOI: 10.1016/j.jep.2023.116843. View

Mohamed Q, Gillies M, Wong T . Management of diabetic retinopathy: a systematic review. JAMA. 2007; 298(8):902-16. DOI: 10.1001/jama.298.8.902. View

Erickson K, Sundstrom J, Antonetti D . Vascular permeability in ocular disease and the role of tight junctions. Angiogenesis. 2007; 10(2):103-17. DOI: 10.1007/s10456-007-9067-z. View

Mouly P, Gaydou E, Estienne J . Column liquid chromatographic determination of flavanone glycosides in Citrus. Application to grapefruit and sour orange juice adulterations. J Chromatogr. 1993; 634(1):129-34. DOI: 10.1016/0021-9673(93)80321-x. View

Choi H, Zhang H, Park H, Choi K, Lee H, Agrawal V . Yes-associated protein regulates endothelial cell contact-mediated expression of angiopoietin-2. Nat Commun. 2015; 6:6943. DOI: 10.1038/ncomms7943. View

Di S, Yao C, Qiao L, Li X, Pang B, Lin J . Exploration of the mechanisms underlying the beneficial effect of Luo Tong formula on retinal function in diabetic rats via the "gut microbiota-inflammation-retina" axis. Chin Med. 2022; 17(1):133. PMC: 9717245. DOI: 10.1186/s13020-022-00688-3. View

10.

Sun H, Breslin J, Zhu J, Yuan S, Wu M . Rho and ROCK signaling in VEGF-induced microvascular endothelial hyperpermeability. Microcirculation. 2006; 13(3):237-47. DOI: 10.1080/10739680600556944. View

11.

Polley S, Oliveira Passos D, Huang D, Mulero M, Mazumder A, Biswas T . Structural Basis for the Activation of IKK1/α. Cell Rep. 2016; 17(8):1907-1914. PMC: 5508515. DOI: 10.1016/j.celrep.2016.10.067. View

12.

Li T, Wang G . Computer-aided targeting of the PI3K/Akt/mTOR pathway: toxicity reduction and therapeutic opportunities. Int J Mol Sci. 2014; 15(10):18856-91. PMC: 4227251. DOI: 10.3390/ijms151018856. View

13.

Simo R, Hernandez C . What else can we do to prevent diabetic retinopathy?. Diabetologia. 2023; 66(9):1614-1621. PMC: 10390367. DOI: 10.1007/s00125-023-05940-5. View

14.

Ren P, Hu H, Zhang R . [Observation on efficacy of puerarin in treating diabetic retinopathy]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2002; 20(8):574-6. View

15.

Miura G . Visual Evoked Potentials for the Detection of Diabetic Retinal Neuropathy. Int J Mol Sci. 2023; 24(8). PMC: 10138821. DOI: 10.3390/ijms24087361. View

16.

Jin D, Zhang Y, Zhang Y, Huang W, Meng X, Yang F . Efficacy and Safety of TangWang Prescription for Type 2 Non-Proliferative Diabetic Retinopathy: A Study Protocol for a Randomized Controlled Trial. Front Pharmacol. 2021; 12:594308. PMC: 8005869. DOI: 10.3389/fphar.2021.594308. View

17.

Ai X, Yu P, Luo L, Sun J, Tao H, Wang X . Berberis dictyophylla F. inhibits angiogenesis and apoptosis of diabetic retinopathy via suppressing HIF-1α/VEGF/DLL-4/Notch-1 pathway. J Ethnopharmacol. 2022; 296:115453. DOI: 10.1016/j.jep.2022.115453. View

18.

Liu L, Zuo Z, Lu S, Liu A, Liu X . Naringin attenuates diabetic retinopathy by inhibiting inflammation, oxidative stress and NF-κB activation and . Iran J Basic Med Sci. 2017; 20(7):813-821. PMC: 5569591. DOI: 10.22038/IJBMS.2017.9017. View

19.

Tu W, Wang H, Li S, Liu Q, Sha H . The Anti-Inflammatory and Anti-Oxidant Mechanisms of the Keap1/Nrf2/ARE Signaling Pathway in Chronic Diseases. Aging Dis. 2019; 10(3):637-651. PMC: 6538222. DOI: 10.14336/AD.2018.0513. View

20.

Heitzig N, Brinkmann B, Koerdt S, Rosso G, Shahin V, Rescher U . Annexin A8 promotes VEGF-A driven endothelial cell sprouting. Cell Adh Migr. 2017; 11(3):275-287. PMC: 5479451. DOI: 10.1080/19336918.2016.1264559. View